Aims and Scope
Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University.
Key Metrics
8.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q1
Drug Discovery
SJR
- Q1 Drug Discovery
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.17
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
8%
4 to 6 months
64%
7 to 9 months
18%
Above 9 months
10%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Assay
- Drug discovery
- Central nervous system
- Rheumatoid arthritis
- Cancer therapy
- CRISPR
- Chagas disease
- Fluorine
- Machine learning
- Artificial intelligence
- Drug development
- Tumor microenvironment
- Adalimumab
- Thioredoxin reductase
- Pharmaceutical industry
- Clinical efficacy
- Cystic fibrosis
- Drug design
- Leptin
- Histone deacetylase
Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Expert Opinion on Drug Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Fragment-based approaches to discover ligands for tumor-specific E3 ligases
- 19 Oct 24
- Expert Opinion on Drug Discovery
-
Full paper
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
- 19 Oct 24
- Expert Opinion on Drug Discovery
-
Full paper
Advances in the design and discovery of next-generation janus kinase-2 (JAK2) inhibitors for the treatment of myeloproliferative neoplasms
- 17 Oct 24
- Expert Opinion on Drug Discovery
-
Full paper
The latest developments in the design and discovery of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV
- 16 Oct 24
- Expert Opinion on Drug Discovery
-
Full paper
Targeting AGAT gene expression – a drug screening approach for the treatment of GAMT deficiency
- 16 Oct 24
- Expert Opinion on Drug Discovery
-
Full paper
Exploring open source as a strategy to enhance R&D productivity.
- 15 Oct 24
- Expert opinion on drug discovery
Scite analysis
Powered by scite_
2k articles received 39.8k citations see all
- 368 Supporting
- 38,884 Mentioning
- 20 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 10 Corrections
- 10 Errata
- 0 Expression of Concern
FAQs
How long has Expert Opinion on Drug Discovery been actively publishing?
Expert Opinion on Drug Discovery has been in operation since 2006 till date.
What is the publishing frequency of Expert Opinion on Drug Discovery ?
Expert Opinion on Drug Discovery published with a Bi-monthly frequency.
How many articles did Expert Opinion on Drug Discovery publish last years ?
In 2023, Expert Opinion on Drug Discovery published 121 articles.
What is the eISSN & pISSN for Expert Opinion on Drug Discovery ?
For Expert Opinion on Drug Discovery,eISSN is 1746-045X and pISSN is1746-0441.
What is Citescore for Expert Opinion on Drug Discovery ?
Citescore for Expert Opinion on Drug Discovery is 8.5.
What is SNIP score for Expert Opinion on Drug Discovery ?
SNIP score for Expert Opinion on Drug Discovery is 1.17.
What is the SJR for Expert Opinion on Drug Discovery ?
SJR for Expert Opinion on Drug Discovery is Q1.
Who is the publisher of Expert Opinion on Drug Discovery ?
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Drug Discovery.